Scientists at The Pirbright Institute and Imperial College London have been awarded a grant by the Biotechnology and Biological Sciences Research Council (BBSRC) to research what makes particular strains of bird flu more likely to adapt to mammalian hosts, and possibly initiate a pandemic.
The Pirbright Institute has been awarded over £1million by the BBSRC-Newton Fund to tackle four major viral diseases that threaten livestock populations across Asia.
Researchers at The Pirbright Institute have created a new method of genetically modifying the Marek’s disease vaccine so that it is able to protect against another destructive poultry virus called infectious bursal disease (IBD), and potentially others such as avian influenza and Newcastle disease
® The Pirbright Institute 2023 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.
